Related Experiment Video
Updated: Jul 13, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Starting a diabetes self-management program in a free clinic
Nilda I Soto1, Laura R Bazyler1, Mary L O'Toole2
1The Open Door Health Center, Homestead, Florida (Dr Soto, Ms Bazyler)
The Diabetes Educator
|August 24, 2007
Summary
Developing a successful type 2 diabetes care system in free clinics is achievable. Innovative collaboration and creative program design, including peer mentorship and community partnerships, are key factors for improving patient self-management and health outcomes.
Area of Science:
- Public Health
- Diabetes Management
- Healthcare Systems
Background:
- Type 2 diabetes poses a significant health burden, particularly in underserved populations.
- Free clinics face challenges in providing comprehensive care due to limited resources.
Purpose of the Study:
- To develop and implement an effective system of care for type 2 diabetes patients within a free clinic setting.
- To improve healthcare delivery and patient outcomes for uninsured individuals with type 2 diabetes.
Main Methods:
- The project was implemented at the Open Door Health Center, a free clinic serving the uninsured.
- Organizational and programmatic changes were introduced, supported by a grant from the Robert Wood Johnson Foundation Diabetes Initiative.
- Program participation, clinical data, community program integration, and collaborations were evaluated.
Main Results:
- Critical factors for successful care included organized medical records, efficient staff resource utilization, and the adoption of 'Popular Education' for patient engagement.
- Involving patients as peer mentors and fostering strong community partnerships were crucial for reinforcing self-management.
- The evaluation assessed program success based on participation, clinical data, and collaborative efforts.
Conclusions:
- A successful system of care for type 2 diabetes in free clinics can be established.
- Innovative collaboration and creative program design are essential for effective diabetes management in resource-limited settings.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...